JP Morgan Chase
LNAI

JP Morgan Chase’s Lunai Bioworks LNAI Stock Holding History

JP Morgan Chase’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19 Sell
6
-4
-40% -$11 ﹤0.01% 7628
2026
Q1 		$34 Hold
10
– – ﹤0.01% 7383
2025
Q4 		$72 Buy
+10
New +$89 ﹤0.01% 7241
2025
Q3 		– Sell
-133
Closed -$3.07K – 7671
2025
Q2 		$3.07K Sell
133
-1,479
-92% -$41.3K ﹤0.01% 6475
2025
Q1 		$70.1K Sell
1,612
-2,811
-64% -$180K ﹤0.01% 5745
2024
Q4 		$296K Buy
4,423
+3,260
+280% +$216K ﹤0.01% 5303
2024
Q3 		$45K Buy
1,163
+903
+347% +$62.6K ﹤0.01% 6030
2024
Q2 		$36.4K Sell
260
-1,244
-83% -$170K ﹤0.01% 5978
2024
Q1 		$319K Buy
1,504
+1,131
+303% +$305K ﹤0.01% 5074
2023
Q4 		$94.5K Buy
+373
New +$102K ﹤0.01% 5759
2023
Q3 		– Sell
-89
Closed -$4.04K – 7686
2023
Q2 		$4.04K Sell
89
-100
-53% -$7.67K ﹤0.01% 6211
2023
Q1 		$14K Buy
189
+49
+35% +$4.31K ﹤0.01% 6054
2022
Q4 		$12K Buy
140
+8
+6% +$1.07K ﹤0.01% 5999
2022
Q3 		$19K Hold
132
– – ﹤0.01% 5820
2022
Q2 		$20K Buy
+132
New +$60.4K ﹤0.01% 5892
2021
Q4 		– Hold
0
– – – 6910
2021
Q3 		– Sell
-3
Closed -$1.47K – 6731
2021
Q2 		$1K Sell
3
-545
-99% -$178K ﹤0.01% 6265
2021
Q1 		$155K Buy
548
+40
+8% +$11.8K ﹤0.01% 5248
2020
Q4 		$120K Buy
508
+369
+265% +$93.2K ﹤0.01% 4958
2020
Q3 		$41K Sell
139
-19
-12% -$5.99K ﹤0.01% 5000
2020
Q2 		$54K Sell
158
-119
-43% -$35.9K ﹤0.01% 4811
2020
Q1 		$66K Buy
277
+37
+15% +$11K ﹤0.01% 4647
2019
Q4 		$97K Buy
240
+224
+1,400% +$98.5K ﹤0.01% 4913
2019
Q3 		$7K Buy
16
+2
+14% +$765 ﹤0.01% 5542
2019
Q2 		$5K Sell
14
-106
-88% -$51.7K ﹤0.01% 5631
2019
Q1 		$66K Buy
+120
New +$70.1K ﹤0.01% 5031

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

JP Morgan Chase's LNAI Position: Q2 2026 in Review

JP Morgan Chase reduced its Lunai Bioworks (LNAI) stake by 40% in Q2 2026, selling an estimated $11 and leaving 6 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #7628.

JP Morgan Chase first reported a position in LNAI in Q1 2019 and has held it in 25 quarters since. The position peaked at $319K in Q1 2024. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • JP Morgan Chase held 6 shares of Lunai Bioworks worth $19 as of Q2 2026.
  • JP Morgan Chase sold 4 Lunai Bioworks shares in Q2 2026, an estimated $11.
  • Lunai Bioworks made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7628 holding.
  • JP Morgan Chase first reported a position in Lunai Bioworks in Q1 2019 and has held it in 25 quarters since.
  • JP Morgan Chase's Lunai Bioworks position peaked at $319K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.